Afya (AFYA) Could Be 15% Undervalued As Margin Expansion Fuels The Narrative

Afya (NasdaqGS:AFYA) has caught investor attention after a sharp 20.7% gain over the past week, outpacing its roughly 6.7% move in the past month and its modest performance over the past three months.

That sharp move comes after a mixed stretch for Afya, with the share price return down 1.34% year to date, but a 7.04% total shareholder return over the past year suggests momentum has started to build again around the current US$14.75 level.

Compare Afya's recent share price momentum with a hand-picked group of education and healthcare-focused stocks, screened for quality and valuation using our 20 high quality undiscovered gems.

Afya now trades at what analysts see as a meaningful discount to their targets and to some estimates of fair value, despite the recent jump. Is the market being sensibly cautious, or is it underpricing this rebound story?

Most Popular Narrative: 14.5% Undervalued

Afya's most followed valuation storyline points to a fair value of $17.25 against the recent $14.75 close, which frames the latest price jump as only a partial catch up to that narrative.

Digital initiatives and cross-segment integration, including Medical Practice Solutions and Continuing Education, are increasing recurring, higher-margin digital revenues and operational synergies. These developments are expected to support sustained net margin expansion and greater earnings stability. The company's focus on operational efficiencies, including centralized shared services and cost controls across all segments, is expected to continue driving SG&A expense dilution and margin expansion, enhancing future net income and free cash flow.

See why 16 investors see Afya as 15% undervalued.

Result: Fair Value of $17.25 (UNDERVALUED)

Still, Afya's story can change if competition for medical students pressures tuition or if higher effective tax rates compress profitability more than analysts currently factor in.

Find out about the key risks to this Afya narrative.

Next Steps

Sentiment around Afya is clearly improving, so it helps to pressure test the optimism against your own read of the numbers and risks. To see which factors investors are most upbeat about right now, review the 4 key rewards.

Looking for more Afya style investment ideas?

If you want to treat Afya as just one idea on a broader watchlist, use structured screeners to spot other opportunities before they move out of reach.

• Target resilient compounding potential by scanning for historically conservative business profiles with the 31 resilient stocks with low risk scores.
• Aim for quality at a sensible entry point by tracking companies that score well on fundamentals using the 28 high quality undervalued stocks.
• Prioritise balance sheet strength and staying power with the list of solid balance sheet and fundamentals (25 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com